Waystar Holding Corp. (NASDAQ:WAY)
| Market Cap | 4.97B-32.8% |
| Revenue (ttm) | 1.21B+19.2% |
| Net Income | 134.79M+56.8% |
| EPS | 0.70+45.6% |
| Shares Out | 191.75M |
| PE Ratio | 36.10 |
| Forward PE | 13.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 227,384.968 |
| Open | 25.80 |
| Previous Close | 25.77 |
| Day's Range | 25.75 - 26.14 |
| 52-Week Range | 17.26 - 40.35 |
| Beta | 0.07 |
| Analysts | Buy |
| Price Target | 32.33(+24.83%) |
| Earnings Date | Nov 4, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About WAY
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$WAY stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in WAY holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WAY's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WAY Estimated quarterly lobbying spending
Source: U.S. Senate LDA
WAY Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Provider | $231.80M | 36.26% |
| Subscription revenue | $176.29M | 27.57% |
| Volume-based revenue | $142.15M | 22.23% |
| Patient | $87.87M | 13.74% |
| Implementation services and other revenue | $1.24M | 0.19% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New WAY patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WAY from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in WAY
| ETF | Est. Holding Size |
|---|---|
| IJRiShares Core S&P Small-Cap ETF | $186.08M |
| VTIVanguard Morningstar Total Stock Market ETF | $96.35M |
| IWMiShares Russell 2000 ETF | $77.15M |
| VBVanguard Morningstar Small-Cap ETF | $69.23M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $39.69M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $38.68M |
Estimated from each fund’s disclosed top holdings × AUM
WAY Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from WAY’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score